NYSE:BAX Baxter International (BAX) Stock Price, News & Analysis $31.20 +0.22 (+0.71%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock About Baxter International Stock (NYSE:BAX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Baxter International alerts:Sign Up Key Stats Today's Range$30.63▼$31.3850-Day Range$27.86▼$36.6452-Week Range$26.25▼$40.70Volume5.55 million shsAverage Volume4.58 million shsMarket Capitalization$16.00 billionP/E RatioN/ADividend Yield2.18%Price Target$38.56Consensus RatingHold Company OverviewBaxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company's products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.Read More… Baxter International Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks87th Percentile Overall ScoreBAX MarketRank™: Baxter International scored higher than 87% of companies evaluated by MarketBeat, and ranked 65th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.2 / 5Analyst RatingHold Consensus RatingBaxter International has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 5 buy ratings, 4 hold ratings, and 1 sell rating.Amount of Analyst CoverageBaxter International has only been the subject of 4 research reports in the past 90 days.Read more about Baxter International's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth10.08% Earnings GrowthEarnings for Baxter International are expected to grow by 10.08% in the coming year, from $2.48 to $2.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Baxter International is -24.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Baxter International is -24.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioBaxter International has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioBaxter International has a P/B Ratio of 1.87. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Baxter International's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.39% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently decreased by 4.90%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldBaxter International pays a meaningful dividend of 2.24%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthBaxter International does not have a long track record of dividend growth.Dividend SustainabilityBased on earnings estimates, Baxter International will have a dividend payout ratio of 24.91% next year. This indicates that Baxter International will be able to sustain or increase its dividend.Read more about Baxter International's dividend. Sustainability and ESG4.0 / 5Environmental Score-1.95 Percentage of Shares Shorted3.39% of the float of Baxter International has been sold short.Short Interest Ratio / Days to CoverBaxter International has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Baxter International has recently decreased by 4.90%, indicating that investor sentiment is improving. News and Social Media2.0 / 5News Sentiment0.53 News SentimentBaxter International has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Baxter International this week, compared to 8 articles on an average week.Search InterestOnly 4 people have searched for BAX on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.MarketBeat FollowsOnly 6 people have added Baxter International to their MarketBeat watchlist in the last 30 days. This is a decrease of -14% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Baxter International insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.21% of the stock of Baxter International is held by insiders.Percentage Held by Institutions90.19% of the stock of Baxter International is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Baxter International's insider trading history. Receive BAX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baxter International and its competitors with MarketBeat's FREE daily newsletter. Email Address BAX Stock News HeadlinesBaxter (BAX) Reports Earnings Tomorrow: What To ExpectApril 30 at 5:42 AM | msn.comBaxter participates in a conference call with JPMorganApril 28 at 12:44 AM | markets.businessinsider.comElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Trump himself said Musk was a "once-in-a-generation industry leader." The president has put him to work as an efficiency czar through the newly created DOGE.April 30, 2025 | Weiss Ratings (Ad)Comparing PolyPid (NASDAQ:PYPD) & Baxter International (NYSE:BAX)April 25, 2025 | americanbankingnews.comBaxter International Inc (BAX) Stock Price Up 3.39% on Apr 23April 23, 2025 | gurufocus.comBaxter International Inc. (NYSE:BAX) Given Consensus Recommendation of "Hold" by BrokeragesApril 23, 2025 | americanbankingnews.comBaxter: Messy, Yet Appealing, If New Management Can DeliverApril 21, 2025 | seekingalpha.comAttorneys for more than 100 international students argue in court against revoked visasApril 18, 2025 | msn.comSee More Headlines BAX Stock Analysis - Frequently Asked Questions How have BAX shares performed this year? Baxter International's stock was trading at $29.16 at the beginning of the year. Since then, BAX shares have increased by 7.0% and is now trading at $31.20. View the best growth stocks for 2025 here. How were Baxter International's earnings last quarter? Baxter International Inc. (NYSE:BAX) released its earnings results on Thursday, February, 20th. The medical instruments supplier reported $0.58 EPS for the quarter, beating analysts' consensus estimates of $0.52 by $0.06. The medical instruments supplier earned $2.75 billion during the quarter, compared to analysts' expectations of $2.67 billion. Baxter International had a positive trailing twelve-month return on equity of 16.67% and a negative net margin of 5.05%. Read the conference call transcript. Does Baxter International have any subsidiaries? The following companies are subsidiaries of Baxter International: Cheetah Medical, ApaTech Limited, Baxter AO, Baxter Belgium SPRL, Baxter (China) Investment Co. Ltd, Baxter Company Ltd, Baxter Corporation (Canada), and others. Who are Baxter International's major shareholders? Top institutional shareholders of Baxter International include Bank of New York Mellon Corp (2.77%), ARGA Investment Management LP (0.26%), Rhumbline Advisers (0.24%) and Sumitomo Mitsui Trust Group Inc. (0.22%). Insiders that own company stock include Jeanne K Mason, Albert P L Stroucken and Jacqueline Kunzler. View institutional ownership trends. How do I buy shares of Baxter International? Shares of BAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Baxter International own? Based on aggregate information from My MarketBeat watchlists, some other companies that Baxter International investors own include Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Exxon Mobil (XOM), Chevron (CVX), JPMorgan Chase & Co. (JPM) and Intel (INTC). Company Calendar Last Earnings2/20/2025Record date for 4/1 Dividend2/28/2025Ex-Dividend for 4/1 Dividend2/28/2025Dividend Payable4/01/2025Today4/30/2025Next Earnings (Estimated)5/01/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:BAX CIK10456 Webwww.baxter.com Phone(224) 948-2000Fax224-948-1813Employees60,000Year Founded1931Price Target and Rating Average Stock Price Target$38.56 High Stock Price Target$45.00 Low Stock Price Target$30.00 Potential Upside/Downside+23.6%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)($1.28) Trailing P/E RatioN/A Forward P/E Ratio12.58 P/E Growth0.93Net Income$-649,000,000.00 Net Margins-5.05% Pretax Margin-0.50% Return on Equity16.67% Return on Assets4.93% Debt Debt-to-Equity Ratio1.31 Current Ratio1.43 Quick Ratio1.09 Sales & Book Value Annual Sales$10.64 billion Price / Sales1.50 Cash Flow$4.84 per share Price / Cash Flow6.45 Book Value$16.69 per share Price / Book1.87Miscellaneous Outstanding Shares512,924,000Free Float509,465,000Market Cap$16.00 billion OptionableOptionable Beta0.64 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (NYSE:BAX) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baxter International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baxter International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.